Prot #MDV3100-13: A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men With High-Risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy

Project: Research project

Project Details

StatusActive
Effective start/end date8/25/178/25/23

Funding

  • Quintiles, Inc. (Prot #MDV3100-13)
  • Medivation, Inc. (Prot #MDV3100-13)